Downregulation and altered spatial pattern of caveolin-1 in chronic plaque psoriasis (Q38454984)

3 September 2017

title

Downregulation and altered spatial pattern of caveolin-1 in chronic plaque psoriasis (English)

1 reference

3 September 2017

1 reference

1 reference

3 September 2017

Campbell L

1 reference

3 September 2017

Laidler P

1 reference

3 September 2017

Watson RE

1 reference

3 September 2017

Kirby B

1 reference

3 September 2017

Griffiths CE

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

British Journal of Dermatology

3 September 2017

published in

1 reference

3 September 2017

volume

147

1 reference

3 September 2017

1 reference

3 September 2017

page(s)

701-709

1 reference

3 September 2017

cites work

Caveolae and caveolins

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Caveolins, liquid-ordered domains, and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Class B scavenger receptors, caveolae and cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Cholesterol and caveolae: structural and functional relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Caveolins in cholesterol trafficking and signal transduction: implications for human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Caveolae and the caveolins in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Signalling via caveolin: involvement in the cross-talk between phosphoinositolglycans and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Inhibition of PKCalpha and rhoA translocation in differentiated smooth muscle by a caveolin scaffolding domain peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Caveolin is an inhibitor of platelet-derived growth factor receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

The cyclin D1 gene is transcriptionally repressed by caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Signal transduction in normal and psoriatic epidermal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

MAP kinase abnormalities in hyperproliferative cultured fibroblasts from psoriatic skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Concentration of caveolin-1 in the cleavage furrow as revealed by time-lapse analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

Calcium signal transduction from caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05009.X

10.1046/J.1365-2133.2002.05009.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference